(Adds Outlook, stock movement)
For the full-year 2025, Surgery Partners, Inc. (SGRY) expects an increase in revenue from the prior year.
For the 12-mponth period, the company expects adjusted EBITDA of $555 to $565 million. Annual revenue is anticipated to be in the range of $3.30 to $3.45 billion, compared with analysts' forecast of $3.39 billion. For the full-year 2024, Surgery Partners has recorded adjusted EBITDA of $508.2 million, on revenue of $3.1 billion.
As of this writing, SGRY is up 3.82 percent at $25 in the pre-market trade on the Nasdaq.
Q4 Result:
Below are the earnings highlights for Surgery Partners.
Earnings: -$108.5 million in Q4 vs. -$1.0 million in the same period last year.
EPS: -$0.86 in Q4 vs. -$0.01 in the same period last year.
Excluding items, Surgery Partners reported adjusted earnings of $55.7 million or $0.44 per share for the period.
Analysts projected $0.38 per share
Revenue: $864.4 million in Q4 vs. $735.4 million in the same period last year.
For comments and feedback: editorial@rttnews.com